Photobiomodulation in Age-Related Macular Degeneration: A Mitochondrial Bioenergetic Framework and Translational Perspective
Life · 30.06.2026 · 16 (7) · 1098
DOI: 10.3390/life16071098 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 30.06.2026. Verfasst von Thomas Desmettre und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Kansas School of Medicine, Prairie Village, KS 66208, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Age-related macular degeneration (AMD) is a leading cause of irreversible visual impairment in aging populations. While effective treatments exist for neovascular AMD and, more recently, geographic atrophy, no widely accepted therapy prevents disease progression in earlier stages. Photobiomodulation (PBM) has emerged as a potential approach to modulate retinal metabolism. This review examines the biological mechanisms proposed to explain PBM effects and explores how mitochondrial physiology may support a bioenergetic framework linking these mechanisms to retinal function in AMD.
Methods
We conducted a targeted review of experimental and clinical literature addressing photobiomodulation, mitochondrial function, and retinal metabolism in AMD.
Results
Experimental studies indicate that PBM may influence mitochondrial activity through multiple mechanisms, including modulation of cytochrome c oxidase, nitric oxide photodissociation, and redox signaling pathways. However, the diversity of mechanisms and variability of clinical outcomes suggest that the biological basis of PBM remains incompletely understood. Emerging insights from mitochondrial physiology, including the debated concept of local thermal microenvironments, support interpreting PBM effects as modulation of mitochondrial bioenergetics rather than isolated molecular pathways.
Conclusions
We propose a conceptual framework in which PBM responses are governed by the interaction between a dose-dependent bioenergetic window and the mitochondrial functional reserve of retinal cells. Within this model, therapeutic effects are most likely when PBM is delivered within an optimal range of stimulation and in retinal tissues where mitochondrial dysfunction remains partially reversible. This framework may help explain variability across studies and support more rational use of PBM in early and intermediate AMD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Kansas School of Medicine, Prairie Village, KS 66208, USA.
- Centre de Rétine Médicale, 187 Rue de Menin, 59520 Marquette-Lez-Lille, France.
- Hemerion Therapeutics, 37 Rue Denis Papin, 59650 Villeneuve-d'Ascq, France.
ORCID-Profile: Thomas Desmettre, Serge Mordon
Zitieren
APA
Desmettre, T., & Mordon, S. (2026). Photobiomodulation in Age-Related Macular Degeneration: A Mitochondrial Bioenergetic Framework and Translational Perspective. Life, 16(7), 1098. https://doi.org/10.3390/life16071098
Vancouver
Desmettre T, Mordon S. Photobiomodulation in Age-Related Macular Degeneration: A Mitochondrial Bioenergetic Framework and Translational Perspective. Life. 2026;16(7):1098. doi:10.3390/life16071098
BibTeX
@article{Desmettre2026,
author = {Desmettre, Thomas and Mordon, Serge},
title = {Photobiomodulation in Age-Related Macular Degeneration: A Mitochondrial Bioenergetic Framework and Translational Perspective},
journal = {Life},
year = {2026},
volume = {16},
number = {7},
pages = {1098},
doi = {10.3390/life16071098}
}
EUVIMED